FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 333:1713-1714 December 21, 1995 Number 25 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Mason, J. W. PubMed Citation

To the Editor: Mason and colleagues report the results of a clinical trial of immunosuppressive therapy for myocarditis (Aug. 3 issue).¹ Ventricular function improved to the same extent among the patients randomly assigned to receive conventional therapy plus immunosuppressive treatment as among those who received conventional therapy alone. McKenna and Davies, in an accompanying editorial, observe that many patients with dilated cardiomyopathy have immunohistochemical evidence of inflammation, even though they may not meet the Dallas criteria for the histologic diagnosis of myocarditis, and the authors allude to the question of a potential role for immunosuppression in the treatment of dilated . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Cunningham, M. W. (2009). Turning Point in Myocarditis. Circ. Res. 105: 403-405 [Full Text]  
• Maisch, B. (2005). Recurrent pericarditis: mysterious or not so mysterious?. Eur Heart J 26: 631-633 [Full Text]  
• Noutsias, M., Pauschinger, M., Schultheiss, H.-P., Kuhl, U. (2002). Advances in the immunohistological diagnosis of inflammatory cardiomyopathy. Eur Heart J Suppl 4: I54-I62 [Abstract]  
• Kuhl, U., Pauschinger, M., Noutsias, M., Kapp, J.-F., Schultheiss, H.-P. (2002). Diagnosis and treatment of patients with virus induced inflammatory cardiomyopathy. Eur Heart J Suppl 4: I73-I80 [Abstract]